Participating Faculty: Clinical and Managed Care Implications of Biosimilars: Evaluating the Science and Challenges to Uptake

Supplements and Featured Publications, Clinical and Managed Care Implications of Biosimilars: Evaluating the Science and Challenges to Upta, Volume 21, Issue 16 Suppl

Publishing Staff

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Director

Christina Doong

Proofreaders

Maggie Shaw

Griselda Demassey

Associate Editor

Jeanne Linke

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Stewart

National Account Managers

Gabrielle Consola

Michael CostellaCorporate

Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

Chief Operating Officer/CFO

Neil Glasser, CPA/CFE

President, Media and Communications

Mike Hennessy, Jr

President, Managed Markets

Brian Haug

Executive Vice President and General Manager

John Maglione

Human Resources Director

Shari Lundenberg

Chief Creative Officer

Jeff Brown

President of Pharmacy Times Continuing Education

David Heckard

Copyright © 2015 by Managed Care & Healthcare Communications, LLC

PARTICIPATING FACULTYFaculty

James G. Stevenson, PharmD, FASHP

Professor College of Pharmacy University of Michigan

Ann Arbor, Michigan

President Visante, Inc St. Paul, Minnesota

Surya C. Singh, MD

Vice President, Specialty Pharmacy

CVS Health Woonsocket, Rhode Island

Karen M. Bagnato, RPh

Executive Advisor Specialty Clinical Innovations and Product Development

CVS Health

Editorial Support

Carol Sardinha

Healthcare Business, Policy, and Medical Communication Consultant

Rockville, Maryland

Debra Gordon

President

GordonSquared, Inc

Williamsburg, Virginia

Faculty Disclosures

James G. Stevenson, PharmD, FASHP, has the following relevant financial relationships with commercial interests to disclose:

Consultant and advisory board member:

Amgen

Surya C. Singh, MD, and Karen M. Bagnato, RPh, have the following relevant financial relationships with commercial interests to disclose:

Stock/shareholder:

CVS Health